Facing fresh pricing threats in D.C., pharma spent a record $92M peddling influence during the first quarter

Facing fresh pricing threats in D.C., pharma spent a record $92M peddling influence during the first quarter
kdunleavy
Wed, 05/05/2021 – 11:00